Literature DB >> 29091261

The Mouse Model of Infection with Citrobacter rodentium.

Nicolas Bouladoux1,2, Oliver J Harrison1, Yasmine Belkaid1,2.   

Abstract

Citrobacter rodentium is a murine mucosal pathogen used as a model to elucidate the molecular and cellular pathogenesis of infection with two clinically important human gastrointestinal pathogens, enteropathogenic Escherichia coli (EPEC) and enterohaemorrhagic E. coli (EHEC). C. rodentium infection provides an excellent model to study different aspects of host-pathogen interaction in the gut, including intestinal inflammatory responses during bacteria-induced colitis, mucosal healing and epithelial repair, the induction of mucosal immune responses, and the role of the intestinal microbiota in mediating resistance to colonization by enteric pathogens. This unit provides detailed protocols for growing this bacterium, infecting mice by intragastric inoculation, measuring bacterial loads in feces and organs, and monitoring intestinal pathology induced by infection. Additional protocols describe steps needed to create frozen stocks, establish a growth curve, perform ex vivo organ cultures, isolate immune cells from the large intestine, and measure immune response by flow cytometry. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  Citrobacter rodentium; colitis; intestinal infection; mouse model

Mesh:

Year:  2017        PMID: 29091261      PMCID: PMC5667658          DOI: 10.1002/cpim.34

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  40 in total

1.  Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.

Authors:  L M Higgins; G Frankel; G Douce; G Dougan; T T MacDonald
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 2.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.

Authors:  Ekaterina P Koroleva; Sydney Halperin; Ekaterina O Gubernatorova; Elise Macho-Fernandez; Cody M Spencer; Alexei V Tumanov
Journal:  J Immunol Methods       Date:  2015-02-19       Impact factor: 2.303

Review 4.  Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia.

Authors:  S A Luperchio; D B Schauer
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

5.  Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium.

Authors:  Siouxsie Wiles; Simon Clare; James Harker; Alan Huett; Douglas Young; Gordon Dougan; Gad Frankel
Journal:  Cell Microbiol       Date:  2004-10       Impact factor: 3.715

6.  Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium.

Authors:  Cameron P Simmons; Simon Clare; Marjan Ghaem-Maghami; Tania K Uren; Joanna Rankin; Allan Huett; Rob Goldin; David J Lewis; Thomas T MacDonald; Richard A Strugnell; Gad Frankel; Gordon Dougan
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis.

Authors:  Ganive Bhinder; Ho Pan Sham; Justin M Chan; Vijay Morampudi; Kevan Jacobson; Bruce A Vallance
Journal:  J Vis Exp       Date:  2013-02-19       Impact factor: 1.355

Review 8.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

9.  Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia.

Authors:  D B Schauer; S Falkow
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Altering host resistance to infections through microbial transplantation.

Authors:  Benjamin P Willing; Anjalee Vacharaksa; Matthew Croxen; Teerawat Thanachayanont; B Brett Finlay
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

View more
  11 in total

Review 1.  Cooperative defenses during enteropathogenic infection.

Authors:  Katia Troha; Janelle S Ayres
Journal:  Curr Opin Microbiol       Date:  2021-11-27       Impact factor: 7.934

2.  Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

Authors:  Timothy J Break; Vasileios Oikonomou; Nicolas Dutzan; Jigar V Desai; Marc Swidergall; Tilo Freiwald; Daniel Chauss; Oliver J Harrison; Julie Alejo; Drake W Williams; Stefania Pittaluga; Chyi-Chia R Lee; Nicolas Bouladoux; Muthulekha Swamydas; Kevin W Hoffman; Teresa Greenwell-Wild; Vincent M Bruno; Lindsey B Rosen; Wint Lwin; Andy Renteria; Sergio M Pontejo; John P Shannon; Ian A Myles; Peter Olbrich; Elise M N Ferré; Monica Schmitt; Daniel Martin; Daniel L Barber; Norma V Solis; Luigi D Notarangelo; David V Serreze; Mitsuru Matsumoto; Heather D Hickman; Philip M Murphy; Mark S Anderson; Jean K Lim; Steven M Holland; Scott G Filler; Behdad Afzali; Yasmine Belkaid; Niki M Moutsopoulos; Michail S Lionakis
Journal:  Science       Date:  2021-01-15       Impact factor: 47.728

3.  Uremia Coupled with Mucosal Damage Predisposes Mice with Kidney Disease to Systemic Infection by Commensal Candida albicans.

Authors:  Chetan V Jawale; De-Dong Li; Kritika Ramani; Li Lin; Kelvin Li; Barbara Methe; Partha Sarathi Biswas
Journal:  Immunohorizons       Date:  2021-01-15

4.  The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells.

Authors:  Katharina A Mayer; Ursula Smole; Ci Zhu; Sophia Derdak; Anastasia A Minervina; Maria Salnikova; Nadine Witzeneder; Anna Christamentl; Nicole Boucheron; Petra Waidhofer-Söllner; Michael Trauner; Gregor Hoermann; Klaus G Schmetterer; Ilgar Z Mamedov; Martin Bilban; Wilfried Ellmeier; Winfried F Pickl; Guido A Gualdoni; Gerhard J Zlabinger
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

5.  Bovine milk derived skimmed milk powder and whey protein concentrate modulates Citrobacter rodentium shedding in the mouse intestinal tract.

Authors:  Julie Cakebread; Alison Hodgkinson; Olivia Wallace; Megan Callaghan; Daralyn Hurford; Robert Wieliczko; Paul Harris; Brendan Haigh
Journal:  PeerJ       Date:  2018-07-27       Impact factor: 2.984

6.  A mouse model of Citrobacter rodentium oral infection and evaluation of innate and adaptive immune responses.

Authors:  Wenyan Wang; Yiping Li; Xiaohuan Guo
Journal:  STAR Protoc       Date:  2020-12-14

7.  Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection.

Authors:  Lara Labarta-Bajo; Steven P Nilsen; Gregory Humphrey; Tara Schwartz; Karenina Sanders; Austin Swafford; Rob Knight; Jerrold R Turner; Elina I Zúñiga
Journal:  J Exp Med       Date:  2020-12-07       Impact factor: 14.307

Review 8.  Type 3 Innate Lymphoid Cells as Regulators of the Host-Pathogen Interaction.

Authors:  Ana Valle-Noguera; Anne Ochoa-Ramos; Maria José Gomez-Sánchez; Aranzazu Cruz-Adalia
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

Review 9.  Staphylococcus aureus Host Tropism and Its Implications for Murine Infection Models.

Authors:  Daniel M Mrochen; Liliane M Fernandes de Oliveira; Dina Raafat; Silva Holtfreter
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

10.  Isolation and Characterization of Bacteriophages That Infect Citrobacter rodentium, a Model Pathogen for Intestinal Diseases.

Authors:  Carolina M Mizuno; Tiffany Luong; Robert Cederstrom; Mart Krupovic; Laurent Debarbieux; Dwayne R Roach
Journal:  Viruses       Date:  2020-07-08       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.